Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public
health concerns globally. The 2015 European C. trachomatis guideline provides: up-to-date …

Lymphogranuloma venereum is a sexually transmitted disease caused by L1, L2, and L3
serovars of Chlamydia trachomatis. In the last 10 years outbreaks have appeared in North …

This guideline offers recommendations on the diagnostic tests, treatment regimens and
health promotion principles needed for the effective management of Chlamydia trachomatis …

Lymphogranuloma venereum appears to have reestablished endemicity among MSM
populations in many industrialized nations. In the relative absence of recent publications …

Lymphogranuloma venereum (LGV) is a sexually transmitted disease (STD) caused by
serovars L1–L3 of Chlamydia trachomatis. Rare in the western world prior to 2003, different …

Background Lymphogranuloma venereum (LGV) is an important re-emerging sexually
transmitted infection which is reported to affect particularly HIV-positive men who have sex …

This guideline is intended for use in UK Genitourinary medicine clinics and sexual health
services but is likely to be of relevance in all sexual health settings, including general …

Background/Objectives Many European countries reported increased numbers of syphilis,
gonorrhoea and chlamydia diagnoses among men who have sex with men (MSM) in recent …

Lymphogranuloma venereum, caused by the L serovars of Chlamydia trachomatis, emerged
in Europe in 2003 and a series of outbreaks were reported in different countries. The …

United Kingdom (UK) national data show a sharp increase in diagnoses of
lymphogranuloma venereum (LGV) since 2012. Most cases are in men who have sex with …